Difference between revisions of "HCmeddev"
(Uploaded V2 of the information session deck) |
(Uploaded V2 of the FRN summary deck) |
||
| Line 15: | Line 15: | ||
*[[Media:Deck Information Session – Feb 2021 V2 EN.pdf|Information session: Regulations Amending the Medical Devices Regulations (February 2021)]] | *[[Media:Deck Information Session – Feb 2021 V2 EN.pdf|Information session: Regulations Amending the Medical Devices Regulations (February 2021)]] | ||
| − | * [[Media:Post-market regulations FRN | + | *[[Media:Deck Post-market regulations – FRN – Jun 2021 V2 EN.pdf|Medical Devices Regulations: Foreign Risk Notification (June 2021)]] |
* | * | ||
Revision as of 16:35, 14 December 2021
Welcome!
This page was developed to share resources related to the new post-market provisions under the Medical Devices Regulations, published in Canada Gazette, Part II on December 23, 2020.
If you have questions, please contact Health Canada's Medical Devices Directorate at mdd.postmarket-postcommercialisation.dim@hc-sc.gc.ca.
Links to online resources
Four guidance documents are available to support the interpretation of the new or updated post-market provisions in the Medical Devices Regulations that were published in Canada Gazette Part II on December 23, 2020. The "List of regulatory agencies and foreign jurisdictions" sets out the regulatory agencies and foreign jurisdictions for the purposes of section 61.2 of the Regulations.
Presentations
Information sessions have been offered by Health Canada related to the new post-market provisions. Presentation slide decks are available for viewing.
- Information session: Regulations Amending the Medical Devices Regulations (February 2021)
- Medical Devices Regulations: Foreign Risk Notification (June 2021)
Questions & answers
Questions & answers documents were prepared in response to enquiries received.
Foreign risk notification (FRN)
Forms
Forms are available to support compliance with the new regulations.
